<DOC>
	<DOCNO>NCT02176668</DOCNO>
	<brief_summary>The objective clinical trial explore pharmacodynamics pharmacokinetics YH4808 New Formulation healthy volunteer .</brief_summary>
	<brief_title>The Exploration Pharmacodynamics Pharmacokinetics YH4808 New Formulation Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>1. healthy adult age 20 55 55kg ideal body weight ( BMI ) 18.5 ~ 25 2 . Subject congenital , chronic disease disease symptoms medical examination result 3. negative Helicobacter pylorus 13C urea breath test 4 . Subject judge eligible accord various test result include laboratory test ( serum test , hematologic/blood chemistry examination , urine test , etc . ) 12lead ECG test perform within 4 week first IP administration . 5 . Subject agree maintain contraception comply medically verified contraception method ( include infertility ) 1 . Subject history presence clinically significant disease liver , kidney , nervous system , respiratory system , endocrine system , blood tumor , cardiovascular , reproductive , musculoskeletal system , mental disorder , ophthalmologic disease , skin disease investigator 's judgement . 2 . Subject history surgical operation disease relate gastrointestinal symptom ( e.g . crohn 's diseas , ulcer , etc . except appendectomy simple hernia ) could influence absorption IP . 3 . Subject hypersensitive component contain YH4808 drug ( aspirin , antibiotic , etc . ) 4. pregnant lactate woman . 5 . Other exclusion apply .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>